IDA
ABBV icon

Intelligence Driven Advisers’s AbbVie ABBV Stock Holding History

Intelligence Driven Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Buy
+1,199
New +$258K 0.05% 106
2023
Q3 		– Sell
-2,879
Closed -$395K – 87
2023
Q2 		$395K Buy
+2,879
New +$422K 0.07% 62

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Intelligence Driven Advisers's ABBV Position: Q2 2026 in Review

Intelligence Driven Advisers opened a new position in AbbVie (ABBV) in Q2 2026: 1,199 shares worth $302K. The stake represents 0.05% of the portfolio and ranks #106 among its holdings. This is a return to the name: Intelligence Driven Advisers previously reported a position in ABBV as recently as Q2 2023.

Intelligence Driven Advisers first reported a position in ABBV in Q2 2023 and has held it in 2 quarters since. The position peaked at $395K in Q2 2023. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Intelligence Driven Advisers held 1,199 shares of AbbVie worth $302K as of Q2 2026.
  • AbbVie was a new Intelligence Driven Advisers position in Q2 2026.
  • AbbVie made up 0.05% of Intelligence Driven Advisers's portfolio in Q2 2026, its #106 holding.
  • Intelligence Driven Advisers first reported a position in AbbVie in Q2 2023 and has held it in 2 quarters since.
  • Intelligence Driven Advisers's AbbVie position peaked at $395K in Q2 2023.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Intelligence Driven Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.